Bisphosphate therapy with zoledronate or tenofovir switching to improve low bone mineral density in HIV-infected adults: A strategic randomised trial

Project: Research

Status	Finished
Effective start/end date	1/01/12 → 31/12/15

Prolonged Effect of Zoledronic Acid on Bone Mineral Density and Turnover in HIV-Infected Adults on Tenofovir: A Randomized, Open-Label Study
Carr, A., Kerr, S. J., Richardson, R., Ebeling, P., Pocock, N., Rojas, J., Martinez, E., Hoy, J. & ZEST Study Investigators, 1 Dec 2019, In: Journal of Bone and Mineral Research. 34, 12, p. 2192-2197 6 p.
Research output: Contribution to journal › Article › Research › peer-review

7 Citations (Scopus)
Zoledronic acid is superior to tenofovir disoproxil fumarate-switching for low bone mineral density in adults with HIV
Hoy, J. F., Richardson, R., Ebeling, P. R., Rojas, J., Pocock, N., Kerr, S. J., Martinez, E., Carr, A. & for the ZEST Study Investigators, 10 Sep 2018, In: AIDS. 32, 14, p. 1967-1975 9 p.
Research output: Contribution to journal › Article › Research › peer-review

15 Citations (Scopus)
Do people with HIV infection have a higher risk of fracture compared with those without HIV infection?
Hoy, J. & Young, B., May 2016, In: Current Opinion in HIV and AIDS. 11, 3, p. 301-305 5 p.
Research output: Contribution to journal › Review Article › Other › peer-review

24 Citations (Scopus)

Project Details